中国を代表するグリチルリチン酸ジカリウムメーカー：世界の化粧品業界向けプレミアム鎮静剤

Why do formulators keep throwing heavy ceramides at an active chemical burn? It defies basic biology. When a consumer applies an aggressive 10% glycolic acid peel, their skin triggers an immediate inflammatory cascade. Ceramides only patch the roof. You need to put out the fire first.

As active ingredient manufacturers in China, we see global brands struggle with soothing claims every single day. They pump their formulas full of bulk botanical waters that look great on a label but do absolutely nothing in the dermis. You need a targeted molecular switch. You need pure Dipotassium Glycyrrhizinate (DPG).

5. 一旦、複雑な化学の話は置いておきましょう。マデカッソシドは実際に何をするのでしょうか？それはツボクサ（Centella）植物に隠された、主要な働きをする分子です。肌の上にただ乗って心地よい感じを与えるだけではありません。それはあなたの細胞と積極的にコミュニケーションをとります。線維芽細胞にコラーゲンIII型をより多く生成するように指示します。これは、肌が傷を治すために必要なまさにそのコラーゲンです。それは細胞の炎症に対する生体消火器のように機能します。

Let us skip the theoretical biology. DPG is a highly refined licorice-derived salt. It acts almost identically to topical corticosteroids, but completely bypasses the dangerous skin-thinning side effects. It physically blocks the enzymes that degrade hyaluronic acid in the skin matrix.

We test this directly in our application labs. We expose living skin models to harsh chemical irritants and measure the subsequent erythema (redness) index over a 24-hour period.

The lab numbers speak for themselves. You use a fraction of a percent. You get double the soothing power.

実際の処方救済

Last autumn, a European clinical brand hit a massive wall. They formulated a high-strength Vitamin C and Retinol night cream. During their initial human patch testing, 40% of the volunteers experienced severe stinging, burning, and red patches. The brand panicked. The marketing team wanted to drop the active anti-aging concentrations to save the product.

We audited their formula on our bench. We told them to keep the aggressive actives exactly where they were. We simply added 0.15% of our DPG powder to their water phase. We instructed them to rerun the patch test.

The stinging complaints dropped to near zero. You do not have to sacrifice aggressive anti-aging efficacy to make a product tolerable. You just need to control the resulting inflammation at the cellular level.

Product Data and COA Realities

You cannot buy raw materials based on generic descriptions from online brokers. The market is flooded with low-grade DPG. It turns yellow in your mixing tank. It smells like wet dirt. It ruins the aesthetic of premium skincare. We manufacture this powder to strict specifications, and as formulators, you must demand this level of purity.

Look closely at the heavy metals limit. Trace iron in your raw material acts as a chemical catalyst. It will ruin your emulsion and degrade your other actives over time. Your regulatory team needs a pristine Certificate of Analysis (COA) to pass strict global compliance checks in the EU and US markets.

Factory Floor Processing Rules

How do you actually mix DPG? It is incredibly robust and forgiving on the factory floor.

Add the powder directly to your water phase. It dissolves instantly in cold or warm water. It survives a massive pH range from 3.0 to 10.0. This makes it the ultimate companion for extreme formulations.

Build smart synergies on the bench. Pair 0.2% DPG with 2% Salicylic Acid in a toner. The acid clears the pore, while the DPG kills the stinging response. Combine 0.15% DPG with 5% Niacinamide to create a powerhouse barrier repair serum that tackles redness and hyperpigmentation simultaneously.

Dermatologists globally are actively warning against long-term steroid use. Consumers actively seek out safe, daily-use soothing agents. Sourcing premium DPG gives you that exact marketing claim backed by hard science. We provide technical samples directly to your R&D lab. Test the powder against your most aggressive peeling acids. Throw the finished formula in your incubator. Let the stability data prove the performance.

References from Public Literature:

1. Shibata, S. (2000). “A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice.” Yakugaku Zasshi, 120(10), 849-862.
2. Saeedi, M., et al. (2003). “The treatment of atopic dermatitis with licorice gel.” Journal of Dermatological Treatment, 14(3), 153-157.
3. Aly, A. M., et al. (2005). “Licorice: A possible anti-inflammatory and anti-ulcer drug.” AAPS PharmSciTech, 6(1), E74-E82.